About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Cpe
carboxypeptidase E
MGI:101932
68 phenotypes from 3 alleles in 4 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Cpefat/Cpefat
BKSChpLt.HRS-Cpefat/J
abnormal hormone level J:80698
abnormal hypothalamus secretion J:80698
abnormal pancreatic beta cell morphology J:24436
abnormal percent body fat/body weight J:10872
decreased circulating adrenocorticotropin level J:40372
decreased circulating gastrin level J:52393
decreased digestive secretion J:52393
degranulated pancreatic beta cells J:10872
hyperglycemia J:10872
impaired adaptive thermogenesis J:80698
increased circulating cholesterol level J:18161, J:19043
increased circulating growth hormone level J:40372
increased circulating HDL cholesterol level J:18161, J:19043
increased circulating insulin level J:10872, J:24436
increased circulating LDL cholesterol level J:19043
increased circulating pituitary hormone level J:38227, J:40372
increased circulating triglyceride level J:19043
increased circulating triiodothyronine level J:80698
increased circulating VLDL cholesterol level J:19043
increased growth hormone level J:40372
increased pituitary hormone level J:40372
infertility J:10872
obese J:10872
pancreatic islet hyperplasia J:10872
Cpefat/Cpefat
involves: HRS/J
abnormal pancreatic beta cell morphology J:10872
degranulated pancreatic beta cells J:13651
hyperglycemia J:10872
hypoglycemia J:13651
increased circulating insulin level J:10872, J:13651
increased pancreatic islet number J:13651
increased total body fat amount J:10872
infertility J:10872
obese J:10872, J:13651
pancreatic islet hyperplasia J:10872
Cpetm1b(EUCOMM)Hmgu/Cpetm1b(EUCOMM)Hmgu
C57BL/6N-Cpetm1b(EUCOMM)Hmgu/Ieg
abnormal behavior J:211773
abnormal locomotor behavior J:211773
aorta stenosis J:211773
decreased body length J:211773
decreased circulating chloride level J:211773
decreased exploration in new environment J:211773
decreased food intake J:211773
decreased grip strength J:211773
decreased locomotor activity J:211773
decreased vertical activity J:211773
hyperactivity J:211773
impaired glucose tolerance J:211773
increased circulating alanine transaminase level J:211773
increased circulating alkaline phosphatase level J:211773
increased circulating aspartate transaminase level J:211773
increased circulating calcium level J:211773
increased circulating glucose level J:211773
increased fasting circulating glucose level J:211773
increased hematocrit J:211773
increased leukocyte cell number J:211773
increased mean corpuscular volume J:211773
increased startle reflex J:211773
increased thigmotaxis J:211773
male infertility J:211773
Cpetm1Yplo/Cpetm1Yplo
involves: 129S1/Sv * C57BL/6
abnormal energy expenditure J:95741
abnormal gait J:95741
abnormal glucose homeostasis J:95741
abnormal hypothalamus secretion J:95741
abnormal motor capabilities/coordination/movement J:95741
abnormal motor coordination/balance J:95741
abnormal muscle physiology J:95741
abnormal physical strength J:95741
abnormal placing response J:95741
decreased grip strength J:95741
decreased locomotor activity J:95741
decreased vertical activity J:95741
hyporesponsive to tactile stimuli J:95741
impaired glucose tolerance J:95741
increased body length J:95741
increased circulating glucose level J:95741
increased circulating insulin level J:95741
increased circulating leptin level J:95741
increased respiratory quotient J:95741
increased total body fat amount J:95741
insulin resistance J:95741
lethargy J:95741
obese J:95741
polyphagia J:95741
reduced fertility J:95741
tremors J:95741

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory